Children's Mercy Kansas City

SHARE @ Children's Mercy
Manuscripts, Articles, Book Chapters and Other Papers
1-1-2018

Risk Factors for Short- and Long-Term Outcomes in Children With
STEC-HUS/D
Judith Sebestyen VanSickle
Children's Mercy Hospital

Tarak Srivastava
Children's Mercy Hospital

Uri S. Alon
Children's Mercy Hospital

Follow this and additional works at: https://scholarlyexchange.childrensmercy.org/papers
Part of the Bacterial Infections and Mycoses Commons, Nephrology Commons, and the Pediatrics
Commons

Recommended Citation
VanSickle JS, Srivastava T, Alon US. Risk Factors for Short- and Long-Term Outcomes in Children With
STEC-HUS/D+ HUS: A Single-Center Experience. Glob Pediatr Health. 2018;5:2333794X18816920.
Published 2018 Dec 4. doi:10.1177/2333794X18816920

This Article is brought to you for free and open access by SHARE @ Children's Mercy. It has been accepted for
inclusion in Manuscripts, Articles, Book Chapters and Other Papers by an authorized administrator of SHARE @
Children's Mercy. For more information, please contact hlsteel@cmh.edu.

816920

research-article2018

GPHXXX10.1177/2333794X18816920Global Pediatric HealthVanSickle et al

Original Article

Risk Factors for Short- and Long-Term
Outcomes in Children With STEC-HUS/
D+ HUS: A Single-Center Experience

Global Pediatric Health
Volume 5: 1–7
© The Author(s) 2018
Article reuse guidelines:
sagepub.com/journals-permissions
https://doi.org/10.1177/2333794X18816920
DOI: 10.1177/2333794X18816920
journals.sagepub.com/home/gph

Judith Sebestyen VanSickle, MD1,2 , Tarak Srivastava, MD1,2,
and Uri S. Alon, MD1,2

Abstract
Background. Hemolytic uremic syndrome (HUS) is one of the common causes for acute kidney injury in childhood.
Objective. The goals of our study were to identify risk factors for short-term complications and long-term outcomes
of chronic kidney disease (CKD) in Shiga toxin–producing Escherichia coli (STEC)-HUS and other diarrhea positive
(D+) HUS. Methods. Retrospective chart review was obtained of 58 pediatric patients treated for STEC-HUS and
other D+ HUS between February 2002 and January 2011. Results. Thirty-three patients (56.9%) required dialysis.
Dialysis was more likely initiated if a patient was a female (P < .012), oliguric (urine output < 0.5 mL/kg/h, P <
.0005), or hemoglobin (HGB) level >10 g/dL (P = .009) at admission. Neurological complications developed only
among 5 dialyzed patients (P < .042), and were more common if the patient received hemodialysis (HD) compared
with peritoneal dialysis (P < .0005). CKD was noted during the subsequent follow-up clinic visits in 5 patients
(8.6%). Those who developed CKD received HD (P = .002), dialysis for >10 days (P = .0004), or HGB level >10
g/dL (P = .034) at admission. Conclusions. Children with STEC-HUS/D+ HUS who may need dialysis are identified by
female gender, lower urine output, higher serum creatinine level, and higher HGB at admission. They are at higher
risk developing central nervous system complications especially if they needed HD. Children requiring >10 days of
dialysis are at risk for development of CKD.
Keywords
STEC-HUS, D+ HUS, HGB level, CNS complications, dialysis, CKD
Received December 7, 2017. Received revised November 6, 2018. Accepted for publication November 8, 2018.

Introduction
Hemolytic uremic syndrome (HUS) is one of the common causes for acute kidney injury (AKI) in children.
HUS is characterized by the triad of microangiopathic
hemolytic anemia, nonimmune thrombocytopenia,
and acute renal failure.1 Diarrhea positive (D+) HUS,
especially Shiga toxin–producing Escherichia coli
(STEC)-HUS receives special attention due to health
services efforts to control epidemic outbreaks.2-4 Our
hospital is an exclusive referral hospital for the surrounding farming/rural area, and thus admission for
STEC-HUS is common. Studies that characterize
demographics, clinical course, and long-term outcomes in children with STEC-HUS from our region
have not been reported. Furthermore, risk factors to
identify children at presentation who are at risk for

having short- and long-term outcomes in STEC-HUS
are still emerging.
We analyzed our experience with STEC- HUS/D+
HUS patients to identify predictors for the development
of complications (need for dialysis, neurologic involvement, colonic perforation, and insulin requirement) and
for the development of chronic kidney disease (CKD) at
the time of presentation to potentially improve the care
such of critically ill children.
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Materials and Methods

Statistical Analysis

This was a retrospective chart review of children admitted
to the Children’s Mercy Hospital, Kansas City, MO,
between February 2002 and January 2011. Fifty-eight
patients were identified by using the specific International
Classification of Diseases, Ninth Revision, Clinical
Modification, admission code. D+ HUS was confirmed by
documented diarrhea prior to presentation, documented
positive stool studies for enterohemorrhagic E coli, evidence of hemolysis by positive peripheral smear for schistocytes, thrombocytopenia, elevated lactate dehydrogenase
level, and abnormal renal function. Children were identified later in the cohort as STEC-HUS when Shiga toxin
testing was established in the microbiology laboratory.
Patients without clinical/laboratory evidence of HUS,
known as atypical HUS, recurrent HUS, or secondary to
Streptococcus pneumonia infection, were excluded.
Data collected from the initial admission and from the
last outpatient follow-up included age, gender, home
address (ZIP code), complete blood count (white blood
cell count [WBC], hemoglobin [HGB], platelet, blood
urea nitrogen level, serum creatinine level), urine output
in the first 24 hour at admission, stool culture result, documentation of preadmission antibiotic therapy, need for
dialysis, hospital day of starting dialysis, type of dialysis
(peritoneal dialysis [PD]), or hemodialysis (HD) initiated,
and length of dialysis. There were 6 patients who transitioned to HD from PD after a short period of time and
were counted into HD group as prevailing type of renal
replacement therapy. Central nervous system (CNS) complications were defined as clinical observation of presence of seizures, documentation of lethargy, reduced
consciousness or altered mental status, started after initiation of dialysis as documented in the medical record. All
participants were seen for regular outpatient follow-up
after discharge from the hospital. Estimated glomerular
filtration rate (eGFR) was calculated by using the bedside Schwartz formula5. The diagnosis of CKD was based
on having an eGFR<90 mL/min/1.73 m2 and/or having
spot proteinuria >0.2 mg/mg at the 5-year follow-up.

Central tendency of continuous variables (interval or
ratio) was measured. The mean values were compared
between the dialyzed and non-dialyzed and CKD and
non-CKD groups by independent t test. Categorical
variables were gender, young age (<2 years), HGB >10
g/dL, WBC >15 × 103/µL, oliguria at admission (<0.5
mL/kg/h urine over the first 24-hour period), the need
for dialysis (yes/no), prolonged dialysis (>10 days),
type of dialysis (HD or PD), preadmission antibiotic
therapy (yes/no), and development of CKD (yes/no).
The categorical variables were assessed by χ2 test for
association, and when the expected frequencies of categorical variables in the 2 × 2 tables were below 5,
Fisher’s exact test was used. Multivariate logistic regression model was developed to assess the role of predictive factors in the severity of acute illness. The statistical
program SPSS 12.0 (SPSS Inc, Chicago, IL) was used to
analyze the data. Statistical significance was defined as
P < .05.

Ethical Considerations
The study was approved by the Children’s Mercy
Hospital Pediatric Institutional Reviewed Board (IRB#:
1109-149E). Due to the retrospective nature, the study
involved chart review of children admitted within the
study period to our institute, who have been already discharged and no personal communication were concluded between participants and the investigators as
well the study proposed no more than minimal risk of
harm without procedure, the study received waiver for
informed consent.

Results
We identified 82 children with the International
Classification of Diseases, Ninth Revision, code of HUS
during the study period. Twenty-four patients were
excluded from the analysis due to wrong diagnosis, having atypical HUS or missing medical documentation,
leaving 58 patients for the final analysis, that is, an average 7.3 cases/year.

Baseline Data at Admission
The mean ± SD age of our cohort was 3.7 ± 2.8 years.
There gender distribution was 58.6% girls and 41.4%
boys. Twenty-eight were <2 years old (48.3%). Shiga
toxin was identified in 43.1% of the cases once the testing was established at our center and the remaining had
shown growth of E Coli to establish the diagnosis of
STEC-HUS/D+ HUS. Complement C3 was measured in
6 children and was low in 2. 28% of children who had
received antibiotic prior to admission. The home address
ZIP code was predominantly from Ozark and Jasper
counties in the State of Missouri and Douglas counties
in the State of Kansas.

Acute Kidney Injury and Need for Dialysis
The standard of care at our institute is to perform PD unless
there is a concern for or an established colonic perforation,
in which case we initiate HD. Dialysis was initiated in 33
cases (56.9%), 25 (75%) received just PD and 7 were transitioned to HD during the course due to extravasation of
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Table 1. Characteristics of Dialyzed Compared to Non-Dialyzed Groups (Independent t Test, P < .05).
Variables
Age (years)
Urine output at admission (mL/kg/h)
Hemoglobin (g/dL)
Creatinine on admission (mg/dL)
WBC (103/µL)
PLT (103/µL)

Non-Dialyzed, n = 25
(Mean ± SD)

Dialyzed, n=33
(Mean ± SD)
3.93 ± 2.98
0.52 ± 1.16
9.19 ± 1.16
3.45 ± 2.55
17.15 ± 7.1
53.87 ± 39.53

3.54 ± 2.59
1.81 ± 0.86
7.45 ± 1.96
1.71 ± 1.14
18.72 ± 14.55
72.31 ± 68.31

P
.61
<.0005
.002
.004
.59
.21

Abbreviations: WBC, white blood cell; PLT, platelet.

PD fluid or significant leak at the exit site, and 1 patient
was started on HD. The mean duration of dialysis was 11.3
± 10.6 days. Dialysis was required for >10 days in 8
(25.9%) children. As shown in Table 1, children who
received dialysis had significantly higher HGB level at
admission, 9.19 ± 2.28 g/dL, compared with the non-dialyzed group, 7.45 ± 1.96 g/dL (P = .002); had significantly
lower urine output, 0.52 ± 1.16 mL/kg/h, versus the nondialyzed group, 1.80 ± 0.86 mL/kg/h (P < .0005); and
serum creatinine on admission was significantly higher in
the dialyzed group, 3.45 ± 2.55 mg/dL, versus 1.71 ± 1.14
mg/dL (P = .004). There was no significant difference
between age, platelet, and WBC count in the 2 groups. As
shown in Table 2 on initial univariate analysis, the odds
ratio (OR) for needing dialysis were female patients compared with male patients, with an OR 4.0 (95% confidence
interval [CI] = 1.32-12.11, P = .012), oliguria at admission, OR 29.57 (95% CI = 5.46-159.97, P < .0005), and
HGB >10 g/dL at admission, OR 5.31 (95% CI = 1.4918.96, P = .007). Younger age (<2 years), previous antibiotic exposure, and WBC count were not associated with
need for dialysis (Table 2).
The significant risk factors for need of dialysis were
entered into the multivariate regression analysis and its
effect were controlled in comparison with gender, oliguria, and HGB >10 g/dL. Oliguria had an OR 30.1
(95%CI = 3.53-255.72, P = .002) and HGB level >10
g/dL had OR 11.16 (95% CI = 1.51-82.22, P = .018),
remaining significant (Table 2). If we remove oliguria
from the equation, HGB >10 g/dL remained the strongest indicator, OR 10.96 (P = .004). As shown in Figure
1, the receiver operating characteristic curve for oliguria
and HGB >10 g/dL at admission as diagnostic test were
good: oliguria AUC (area under the curve) 0.83 (95% CI
= 0.71-0.95, P < .005) and HGB >10 g/dL AUC 0.67
(95% CI = 0.53-0.81, P = .02).

Acute Nonrenal Complications
Neurological complication developed in 5 children (8.6
%). Patients who received dialysis developed severe

neurological complications after initiation of dialysis
significantly more often (OR = 1.18 [95% CI = 1.021.36], P = .042) and even more likely if they received
HD (OR = 49 [95% CI = 4.37-549.25], P < .005).
Neurological complications were not associated with
HGB level >10 g/dL at admission, PD, younger age
(<2 years), or previous antibiotic exposure (Table 1).
We had no gastrointestinal perforation, need for insulin
therapy, and we had 1 death in our cohort.

Long-Term Complications
Follow-up information was available in all 58 cases
from their annual clinic visits. All 5 out of 58 patients
(8.6%) who were later diagnosed with CKD received
dialysis during the acute phase. There was a significant
difference in CKD rate between HD and PD treated
patients. CKD was noted in 3 out of 8 HD (37.5%) compared with 2 out of 25 PD (8%) patients (P = .016).
Patients who developed CKD had higher HGB level at
admission (10.7 ± 2.64 vs 8.99 ± 2.22 g/dL, P = .034).
There was no significant difference between the length
of dialysis among PD and HD patients during the acute
phase. However, receiving dialysis for >10 days was
associated with the development of CKD regardless of
dialysis modality (OR = 15.27 [95% CI = 1.55-150.76],
P = .013). There was no significant association between
CKD and gender, younger age (<2 year), previous antibiotic therapy, oliguria, or leukocytosis. Due to low
number of patients with CKD we were not able to perform logistic regression. The changes in eGFR of CKD
patients are displayed on Figure 2.

Discussion
Our goal was to identify risk factors at the time of initial
presentation for the development of severe acute course
manifested by a need for dialysis as well for the development of chronic long-term sequelae in our STECHUS/D+ HUS patients. Children who eventually
required dialysis had significantly higher serum HGB
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Figure 1. Receiver operating characteristic (ROC) curve of urine output <0.5 mL/kg/h (blue line) and hemoglobin (HGB)
>10 g/dL (green line) at admission for patients, who required dialysis. ROC for oliguria at admission = 0.83 (P < .005, 95%
CI = 0.71-0.95). ROC for HGB >10 g/dL at admission = 0.67 (P = .02, 95% CI = 0.53-0.81).

Figure 2. Changes in glomerular filtration rate over 5 years of patients’ who developed chronic kidney disease.
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Table 2. Predictor for Need to Initiate Dialysis in Pediatric Patients Admitted With STEC/D+ HUS (Fisher’s Exact Test and
Logistic Regression, P < .05).
Variable
<2 years old
Female
Antibiotic exposure
Urine output <0.5 mL/kg/h
WBC >15 × 103/µL
Hemoglobin >10 g/dL
CNS involvement

Dialyzed, n = 33 Non-Dialyzed, n =
(Mean ± SD)
25 (Mean ± SD)
15/33
24/33
11/30
23/30
18/33
17/33
5/33

13/25
10/25
3/25
2/25
8/25
4/25
0/25

Univariate Odds
Ratio (95% CI)
0.77 (0.27-2.18)
4 (1.32-12.11)
3.28 (0.78-13.77)
29.57 (5.46-159.97)
2.4 (0.81-7.14)
5.31 (1.49-18.96)
1.17 (0.41-0.68)

P

Multivariate Odds
Ratio (95% CI)

P

.62
.01 3.02 (0.43-21.17) .26
.09
<.005 30.1 (3.53-255.72) .002
.112
.007 11.16 (1.51-82.22) .018
.04

Abbreviations: WBC, white blood count; CNS, central nervous system.

level, lower urine output, higher serum creatinine level
at admission, and they were more likely female (Tables
1 and 2). Patients more likely developed CNS complications if they received HD compared with PD. In contrast
to earlier literature, younger age, leukocytosis, and antibiotic exposure were not linked with need for dialysis in
our analysis. Oliguria and HGB >10 g/dL remained to
be independent predictors in multivariate analysis.
HUS is one of the most frequent causes of AKI in
infants and children.1 Previous retrospective studies
found several contributing factors for the development
of severe AKI secondary to HUS. Antibiotic exposure
during the diarrhea phase has been questioned to be
associated with more likely development of HUS.6
Similarly leukocytosis and younger age have been
linked with severe acute course,7 but previous metaanalysis of 49 studies found inconsistent relationship
with acute and chronic sequelae.8 Though age appeared
to have no significant role in our study, our study population included mainly younger patients in both dialyzed
and non-dialyzed groups compared with previous
reports. Similar to our finding female gender has been
linked with worse outcome in other studies.8,9 The
mechanism of an increased risk of HUS among females
remains to be determined. Factors such as lower body
surface area versus similar toxin load or increased adherence of verotoxigenic E coli have been speculated.9
Hydration has been shown to be protective prior to
development of HUS in diarrhea positive E coli infection.10 Several studies demonstrated higher HGB level
on admission to be associated with increased morbidity
and mortality during the acute phase.7,11 It is possible
that the relatively high serum HGB level despite ongoing hemolysis in HUS patients may reflect dehydration
causing prerenal injury aggravating the ongoing intrinsic renal disease11 and increasing risk for rapid progression. However, recently the concept of higher HGB
level was reevaluated and association was found with

severe neurological complication among patients who
received HD.12 Furthermore, it may be speculated that
patients with higher HGB level may develop worsening
hemoconcentration during HD due to fluid removal
favoring more microthrombi formation causing ischemic tissue injury in other organs, including CNS system and kidneys.12 Additionally, in HUS prior to the
development of renal injury, thrombin generation due to
accelerated thrombogenesis and inhibition of fibrinolysis can be detected as elevated plasminogen-activator
inhibitor type 1 (PAI-1)13,14 level. While PAI-1 level
increases in patients who receive chronic HD13 and PD
has been detected to reduce PAI-1 level in HUS
patients.15
Oliguria on admission was a significant risk factor
for need of dialysis in univariate and in multivariate
analyses in our study. This correlates with previous finding as higher morbidity rate was identified in oliguric
acute renal failure compared with nonoliguric acute
renal failure.16 HGB >10 g/dL at admission was an
independent and strong risk factor for need of dialysis.
We feel that an elevated HGB level with an ongoing
hemolytic process should raise the clinician’s attention
to dehydration and also for higher risk of microthrombi
formation during HD as it also correlated with increased
risk for CNS complications in the HD population. As
that, gentle fluid removal during dialysis in an oliguric
patient with a relatively higher HGB level despite ongoing hemolysis is probably preventive of further neurological complications.11 Higher HGB level at admission
additionally to hyponatremia has been recently reported
as an independent risk factor for increased morbidity
and mortality.17
Most of the patients are able to recover their renal
function even after severe STEC-HUS/D+ HUS. In our
study, we had no patients who developed end-stage renal
disease yet we found prolonged dialysis (>10 days) to
be significantly associated with mild form of CKD
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during follow-up. Per the authors’ best knowledge,
modality of dialysis has not been investigated as a risk
factor for CKD in HUS patients. In our small study, we
observed significantly higher number of patients with
CKD from the HD group compared with the PD group.
In our institute, children with HUS at that time mainly
received PD as the preferred dialysis modality due to
patient size, and just a minority of our patients were chosen to receive primarily HD. A few patients were transitioned to HD due to PD-related complications as well.
Due to our study design and low number of subjects, we
cannot rule out incidental allocation of more severe
cases to receive HD. However, if elevated HGB level on
admission may reflect hemoconcentration as sign of
existing prerenal failure, more aggressive fluid removal
during HD in these patients may cause further microthrombus formation causing more extended ischemic
injuries and higher risk not just for CNS complications
but also for CKD.11,12,17
Our finding of severe acute illness relating to higher
incidence of CKD is correlating with previous study outcomes. Oakes et al18 found an increased prevalence of
CKD in their dialyzed HUS patients who had anuria for
more than 5 days. Garg et al8 reviewed 49 studies to
quantify the long-term prognosis of diarrhea positive
pediatric HUS patients. In their meta-analysis they found
25% demonstrating long-term renal sequelae during their
follow-up. The severity of acute illness, particularly CNS
complications, prolonged anuria, and need for dialysis
>4 weeks, was associated with worse long-term prognosis. Similarly to our finding both studies recommended
long-term follow-up of HUS patient to detect late development of CKD even if the renal function was recovered
by the time of hospital discharge.8,18

Conclusions
The severity of acute disease with need of dialysis in
pediatric patients with STEC-HUS/D+ HUS can be predicted on admission by gender, HGB level, serum creatinine level, and urine output. Severe neurological
complications maybe more likely to develop due to
hemoconcentration during HD. Therefore, fluid status of
anuric patients should be cautiously interpreted together
with serum HGB level. The risk for development of
CKD can be predicted based on the severity of the acute
illness, including higher HGB level on admission potentially reflecting prerenal injury, need of dialysis, or by
the length of dialysis during the acute disease.
Our study has several limitations including retrospective design and small patient number. Therefore, the
authors feel the role of different dialysis modalities in
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preventing further complications need to be further
investigated in the future.
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